Abstract
The present invention relates to compounds capable of inhibiting p38a-Kinase, to pharmaceutical compositions comprising these compounds, and to methods of using the compounds for the treatment or prevention of diseases or disorders that are mediated by p38-a Kinase, particularly for the treatment or prevention of inflammatory diseases and disorders and heart conditions.
| Original language | American English |
|---|---|
| Patent number | WO2006018842 |
| Priority date | 23/08/04 |
| State | Published - 23 Feb 2006 |